Kingcat
2022-10-10

$Moderna, Inc.(MRNA)$slower growth in vaccine sales post pandemic doesn't mean no growth. They are in a strong cash position and price is also starting to look attractive. More downside possible in the short term but upside even more in the longer term. 

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • PagRobinson
    2022-10-10
    PagRobinson
    Don't buy easily. At present, it is still in the stage of stock price adjustment. Wait patiently for the low price of the stock.
  • AthenaVeblen
    2022-10-10
    AthenaVeblen
    I think the main reason why it is worth buying is that the current price is very low. But whether it can rise depends on its future income.
  • EricVaughan
    2022-10-10
    EricVaughan
    It needs to prove to the market that it has many vaccines that sell well. Otherwise, its share price will fall to the level before 2019, or even lower.
    • breAkdaWn: 

      not only sell well! WE need a vaccine which is a real vaccine! and a cure!. dont beat around the bush moderna!

Leave a comment
6